Publications by authors named "Stephen Forman"

Claim this Profile
T
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.
Jose Tinajero, Kim Nguyen, Dat Ngo, Vaibhav Agrawal, Haoyue Shan, Stephen Forman

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration.
Lei Gao, Avyakta Kallam, Geoffrey Shouse, John H Baird, Stacy Pak, Stephen J Forman

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.
Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Alysia Bosworth, Elizabeth Ross, Stephen J Forman

J Natl Cancer Inst· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia.
Kaito Harada, Dandan Zhao, Miso Park, Fang Chen, Yongfang Xu, Stephen J Forman

J Hematol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.
Amandeep Salhotra, Dongyun Yang, Monzr M Al Malki, Sally Mokhtari, Diana Knobler, Stephen Forman

Bone Marrow Transplant· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelofibrosis-associated extramedullary hematopoiesis: Insights into hepatic, pulmonary, and thrombotic complications.
Idoroenyi Amanam, Salman Otoukesh, Vinod Pullarkat, Stephen Forman, Guido Marcucci

Blood Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report.
Nora Balas, Joshua Richman, Wendy Landier, Lindsey Hageman, Qingrui Meng, Stephen J Forman

Bone Marrow Transplant· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal Impairment.
Tina Nguyen, Tanya Markary, Ni-Chun Tsai, Katrin Tiemann, Sally Mokhtari, Stephen J Forman

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-selective telomere damage by thiopurine-based oligonucleotide for diffuse large B cell lymphoma immunotherapy.
Chunsong Yu, Elaine Y Kang, Dongfang Wang, Yong Liang, Piotr Swiderski, Stephen Forman

Mol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Brexucabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma.
Tamer Othman, John H Baird, Yan Wang, Stacy Pak, Hannah Zhong, Stephen J Forman

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.
Hoda Pourhassan, Jose Tinajero, Huiyan Ma, Ryan Jackson, Raju Pillai, Stephen Forman

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery.
John P Murad, Lea Christian, Reginaldo Rosa, Yuwei Ren, Alyssa J Buckley, Stephen J Forman

Nat Biomed Eng· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR Knockdown of CHIP Genes in Macrophages Drives Increased Production of Inflammatory Cytokines in CAR-T Cell Therapy.
Chunyan Zhang, Scott R Goldsmith, Myo Htut, June-Wha Rhee, Vibhuti Vyas, Stephen J Forman

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy.
Lior Goldberg, Eric R Haas, Jiaqi Wu, Bryan Garcia, Ryan Urak, Stephen J Forman

bioRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.
June-Wha Rhee, Sitong Chen, Raju Pillai, Alysia Bosworth, Artem Oganesyan, Stephen J Forman

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Enasidenib Maintenance Post-Allogeneic Hematopoietic Cell Transplantation in Patients with IDH2-Mutated Acute Myeloid Leukemia.
Amandeep Salhotra, Nelli Bejanyan, Dongyun Yang, Sally Mokhtari, Diana Knobler, Stephen J Forman

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission.
Ibrahim Aldoss, Mary C Clark, Stephen J Forman

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission.
Jose Tinajero, Dat Ngo, Maria Motta, Vaibhav Agrawal, Paul Koller, Stephen Forman

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors.
Anthony K Park, Isabel Monroy, Yuwei Ren, Cathy Lu, Shyambabu Chaurasiya, Stephen J Forman

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety.
Michael E Barish, Maryam Aftabizadeh, Jonathan Hibbard, M Suzette Blanchard, Julie R Ostberg, Stephen J Forman

Cell Rep Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annual household income and chronic pulmonary conditions in long-term survivors of blood or marrow transplantation: a BMTSS report.
Trisha M Parekh, Rekha Ramachandran, Young-Il Kim, Nora Balas, Wendy Landier, Stephen J Forman

BMC Pulm Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ifosfamide, carboplatin, and etoposide are a highly effective first salvage regimen in high-risk relapsed/refractory Hodgkin lymphoma.
Matthew Mei, Joycelynne Palmer, Hun Ju Lee, Iris Isufi, Robert Chen, Stephen J Forman

Hemasphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 delivery.
John P Murad, Lea Christian, Reginaldo Rosa, Yuwei Ren, Eric Hee Jun Lee, Stephen J Forman

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal single cell RNA-sequencing reveals evolution of micro- and macro-states in chronic myeloid leukemia.
David E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Stephen Forman

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies.
Lawrence A Stern, Vibhuti Vyas, Laura Lim, Christian Huynh, Ryan Urak, Stephen J Forman

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis